OPTN and glaucoma: This mechanism of by NF-κB regulation by OPTN is supported by the findings, which show that a glaucoma-associated mutant of OPTN, H486R, is defective in interaction with CYLD and is unable to inhibit TNFα-induced NF-κB activation (60).